Privia Health (PRVA) news
Recent news
Privia Health sees year adj EBITDA mid to high end $145M-$155M
Privia Health Group, Inc. (Nasdaq: PRVA) reported strong financial performance for the full year 2025, with all operating and financial metrics exceeding the high end of its guidance ranges. The company’s adjusted EBITDA for 2025 reached $125.5 million, reflecting a 38.8% increase compared to 2024…
AInvest Wire · Aug 6, 2026PRVA sees FY revenue high end of $2.35B to $2.45B, estimated $2.43B
Privia Health Group, Inc. (Nasdaq: PRVA) has reiterated its full-year 2023 guidance, with projected revenue at the high end of its range estimated at $2.43 billion, according to the company’s first-quarter 2023 financial report. The company’s guidance for GAAP revenue in FY 2023 ranges between…
AInvest Wire · Aug 6, 2026Privia Health raises FY24 guidance to mid to high end for all metrics
Privia Health raises FY24 guidance to mid to high end for all metrics Privia Health Group, Inc. (Nasdaq: PRVA), a leading healthcare organization specializing in value-based care, reported its second-quarter 2024 financial results on August 8, 2024. The company showcased robust execution across all…
AInvest Wire · Aug 8, 2024Privia Health Q3 adj EPS 17C, est 14C
AInvest Wire · Nov 3, 2023Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.